The company Pharma Stulln located in the BioRegion Regensburg is looking back on 60 successful years in the production of sterile pharmaceuticals. On a clean room area of 1,000 sqm the company has been in successful production since 1953 in Upper Palatinate.
Already in summer the German-French group of Eurofins Scientific had taken over the gene synthesis firm Entelechon located in Bad Abbach. Entelechon’s subsidiary company for protein analysis has remained independent.
On the site of the former Nibelungen Barracks in Regensburg, with the first breaking of the grounds, the construction of the new Innovation Centre Regensburg (IZR) began and will commence its operation in 2016.
The PreSens company, located in BioPark Regensburg, is developing in various projects throughout Europe sensor technology for novel devices to culture cells. PreSens is meanwhile one of the leading companies in the development, production and marketing of chemical optical sensors.
The Regensburg company rent a scientist has always identified lucrative gaps in the market and translated these into new business ideas. The company with its subsidary ras materials GmbH is part of the innovative Network Nanosilber for the further development of a highly modern novel active substance.
The CEO of BioPark Regensburg GmbH Dr. Thomas Diefenthal was reelected to the Board of ADT, the German Association of Innovation, Technology and Business Incuabtion Centres with its headquarters in Berlin.
Through the IA-BIOTECH Initiative at BioPark Regensburg GmbH the network BioRegio Regensburg in East Bavaria has been enriched by two innovative companies. Inotech Kunststofftechnik GmbH produces innovative products for medical technology. Kelheim Fibres is a world market leader for specialised viscose fibres for clinical and hygiene fields.
Haupt Pharma Amareg GmbH, amongst of one of the leading European companies for pharmaceutical contract development and manufacturing, celebrated its 10 year company anniversary with a large celebration on the company grounds. The company looks back on a long tradition in the manufacturing of medicines with solid development and also expects further expansion of production and personnel in the future.
The Council of German BioRegions chose the new Spokespersons Committee for the coming two years. The managing director of STERN management GmbH, Dr. Klaus Eichenberg, was reelected as spokesperson. Dr. Thomas Diefenthal of BioPark Regensburg GmbH was confirmed is his office as acting spokesperson. New to the team as acting spokesperson is Dr. Heinrich Cuypers, senior project manager of BioCon Valley GmbH from Greifswald.